Dr. Joseph Kim Headshot
Report a problem with this profile
[email protected]

Dr. Joseph Kim  

Co-Founder and CEO of biotech company Inovio

Joseph Kim was appointed President and CEO of Inovio Pharmaceuticals in 2009. Dr. Kim co-founded VGX Pharmaceuticals, a synthetic vaccine company, in 2000 to develop intellectual property related to immunotherapeutics licensed from the University of Pennsylvania. He led that company for nine years and combined VGX with Inovio Biomedical in 20009 to form Inovio Pharmaceuticals. Previously, Dr. Kim was a senior vaccine developer at Merck & Co. where he successfully led efforts in manufacturing and process development for several FDA-approved products for hepatitis and developmental vaccines and therapeutics for HIV/AIDS.

Dr. Kim earned a Bachelor of Science degree in Chemical Engineering and Economics from the Massachusetts Institute of Technology (MIT), where he was a U.S. Senate Honors Scholar. He holds a PhD in Biochemical Engineering from the University of Pennsylvania and a Master of Business Administration degree in Finance from the Wharton School. Dr. Kim has published more than 100 peer-reviewed scientific papers, holds numerous patents and sits on several editorial boards and review panels.


Zika vaccine maker's stock is on fire - Jun. 22, 2016
... by the virus are expanding, not contracting," said Inovio CEO Dr. Joseph Kim in a ... Inovio CEO Kim has said in recent television interviews with CNBC and ...
Drug companies search for Zika vaccine - CNN Video
CNN's Maggie Lake talks to Joseph Kim from Inovio Pharmaceuticals about the methods of developing a vaccine and a timetable for testing.

Related Speakers View all

More like Joseph